Open | - |
Close | - |
Volume / Avg. | 0 / 1.200M |
Day Range | - - - |
52 Wk Range | 11.215 - 25.340 |
Market Cap | $1.960B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | - |
Days to Cover | 6.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Syndax Pharmaceuticals (NASDAQ: SNDX) through any online brokerage.
Other companies in Syndax Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Syndax Pharmaceuticals (NASDAQ: SNDX) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 41.00 expecting SNDX to rise to within 12 months (a possible 77.72% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $23.07 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Syndax Pharmaceuticals.
Syndax Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Syndax Pharmaceuticals.
Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.